CRTX - Cortexyme - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Cortexyme's activity chart (see below) currently has 16 price targets and 19 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 77.5% with an average time for these price targets to be met of 159.92 days.

Most recent stock forecast was given by from MORGAN STANLEY on 11-May-2022. First documented stock forecast 03-Jun-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell Since 26-Apr-2021

$3.5

$2.17 (163.16%)

$14

4 years 4 months 3 days ago
(11-May-2022)

1/2 (50%)

$0.36 (11.46%)

184

Buy Since 05-Apr-2022

4 years 5 months 9 days ago
(05-Apr-2022)

1/2 (50%)

$59.58 (65.89%)

15

Buy Since 24-Jun-2020

$15

$13.67 (1027.82%)

$30

4 years 6 months 5 days ago
(09-Mar-2022)

2/5 (40%)

$10.18 (211.20%)

293

Hold Since 27-Jan-2022

$53

4 years 7 months 18 days ago
(27-Jan-2022)

1/1 (100%)

$28.87 (119.64%)

200

Sell Since 11-Dec-2020

$5

4 years 10 months 3 days ago
(11-Nov-2021)

3/3 (100%)

$-8.51 (-62.99%)

155

Show more analysts

Please expand the browser size to see the chart

What is CRTX (Cortexyme) average time for price targets to be met?

On average it took 160 days for the stock forecasts to be reached, with an average price target met ratio of 77.5%.

Which analyst most recently updated their price target on CRTX (Cortexyme)?

Which analyst has the most public recommendations on CRTX (Cortexyme)?

has 0 price targets and 0 ratings on CRTX

Which analyst is the currently most bullish on CRTX (Cortexyme)?

Biren Amin with the highest potential upside of $32.67

Which analyst is the currently most reserved on CRTX (Cortexyme)?

Sumant Kulkarni with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?